InnovationRx: A New Blood Thinner On The Horizon
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: forbes.com
Dan Bloomfield News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Dan Bloomfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Dan Bloomfield Today - Breaking & Trending Today
Anthos Therapeutics' Novel Dual-Acting Factor XI/XIa Inhibitor, Abelacimab 150 mg, Demonstrated a 67% Reduction in the Primary Endpoint of Major or Clinically Relevant Non-Major Bleeding Compared with Rivaroxaban in Patients with Atrial Fibrillation
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 12, 2023--
Source: eagletribune.com
Trial Halted for Bleeding Reduction With Abelacimab in AF
The phase 2 AZALEA-TIMI 71 trial in AF shows "an overwhelming reduction" in major and clinically relevant nonmajor bleeding with investigational Factor XI inhibitor abelacimab vs rivaroxaban.
Source: medscape.com
Anthos Stops Mid-Stage Atrial Fibrillation Trial Due to 'Unprecedented' Efficacy
After evidence of “overwhelming reduction” in bleeding compared to Bayer and J&J’s Xarelto, Anthos Therapeutics has ended its Phase II atrial fibrillation study for abelacimab ahead of schedule.
Source: biospace.com